SCHEMBL24257712

SCHEMBL24257712

CCOC(=O)CNC(=O)c1ncc(-c2cnn(C3CCN(C(=O)OC(C)(C)C)CC3)c2)c(C)c1OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TNK2 Q07912 1/20 0.44
LMNA P02545 2/20 0.42
THRB P10828 1/20 0.42
MET P08581 2/20 0.42
TDP1 Q9NUW8 1/20 0.41
HTT P42858 1/20 0.40
TP53 P04637 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
TTK P33981 1/20 0.39
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
NTSR1 P30989 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30452371 1.00 MEN1 (0.48) MEN1KMT2ATNK2LMNATHRB
SCHEMBL24257696 0.88 TNK2 (0.48) TNK2LMNATHRBMETTTK
SCHEMBL24257594 0.87 IRAK4 (0.38) MEN1KMT2AL3MBTL1
SCHEMBL24257786 0.86 MET (0.44) MEN1KMT2ATNK2LMNATHRB
SCHEMBL30546843 0.86 MET (0.44) MEN1KMT2ATNK2LMNATHRB
SCHEMBL30453163 0.82 TNK2 (0.47) TNK2METGPR119TTK
SCHEMBL24257799 0.82 TNK2 (0.47) TNK2METGPR119TTK
SCHEMBL24257505 0.80 TNK2 (0.45) TNK2LMNAMETTDP1L3MBTL1
SCHEMBL24257745 0.79 GRM4 (0.42) MEN1KMT2ATP53L3MBTL1
SCHEMBL24257538 0.78 KMT2A (0.39) MEN1KMT2ALMNATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670131-A PHD inhibitor compounds, compositions, and methods of use 阿克比治疗有限公司 2023-08-29 CN disclosed
WO-2022036188-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE AKEBIA THERAPEUTICS, INC. (US) 2022-02-17 WO disclosed